Status:
RECRUITING
Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome Patients
Lead Sponsor:
Hospital General de Mexico
Conditions:
Alcohol Withdrawal Syndrome
Eligibility:
All Genders
18-80 years
Brief Summary
The goal of this observational study is to describe the impact measured through the Odds Ratio (OR) of different variables of clinical and biochemical alterations on the duration of the syndrome alcoh...
Detailed Description
Clinical records (files) of patients with a diagnosis of admission of alcohol withdrawal syndrome (AAS) who have been treated in the Department of Internal Medicine for 5 years.
Eligibility Criteria
Inclusion
- Clinical records of patients, both genders, over 18 years of age with Alcohol Withdrawal Syndrome according to the criteria for alcohol withdrawal.
- Clinical records of candidates for admission for neurological monitoring and with criteria for use of sedative drugs according to the CIWA-Ar scale
- Clinical records of patients containing the CIWA-Ar scale score at diagnosis
Exclusion
- Clinical records of patients who already have a history of seizures or epilepsy
- Clinical records of diabetic patients with diabetic ketoacidosis
- Clinical records of patients who have not received any type of sedative treatment
- Clinical records of patients with chronic liver failure or liver cirrhosis
- Clinical records of patients with chronic liver disease with signs of hepatic encephalopathy
- Clinical records of patients with related toxic-alcoholic hepatitis
- Clinical records of patients with a life expectancy of less than 24 hours due to associated complications such as head trauma or other associated complications
- Clinical records of patients who require intubation and mechanical ventilation upon admission
- Clinical records of patients who have a vascular event that modifies the neurological evaluation
- Clinical records of patients who before admission show psychomotor alteration or neurological deterioration that modifies the neurological evaluation such as the presence of Wernicke's encephalopathy
Key Trial Info
Start Date :
September 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2025
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT06589973
Start Date
September 9 2024
End Date
February 28 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General de Cuautitlan "General José Vicente Villada"
Mexico City, Mexico, 54800